Kit for simultaneously detecting DNA (deoxyribonucleic acid) content and fragment size distribution of CHO (Chinese hamster ovary) cells and application thereof

By designing multiple sets of primers, probe combinations and real-time fluorescence quantitative PCR technology, the problem that the existing technology cannot simultaneously detect the DNA content and fragment size distribution of CHO cells is solved, and high sensitivity detection of DNA in biological products is achieved, which improves the biological Safety and quality control of products.

CN118995948APending Publication Date: 2024-11-22JIANGSU ANHUAJIE TESTING TECHNOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411213967.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-31
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art cannot simultaneously detect the content and fragment size distribution of residual DNA of CHO cells in biological products, which poses safety risks, and the sensitivity of the existing methods is not sufficient to meet strict regulatory requirements.

Method used

Provide a kit that uses the long scattered repeat sequence (LINE-1) of the CHO cell genome as a detection target, designs multiple sets of primers and probe combinations, and combines real-time fluorescence quantitative PCR technology to simultaneously detect DNA content and fragment size distribution. It includes four combinations of amplification products with a length of less than 100 bp, 100-200 bp, 200-300 bp and 500 bp or more. It uses a dual quenching probe and an internal PCR control system to ensure the accuracy and reliability of the detection.

Benefits of technology

The precise quantity detection of CHO cell DNA in biological products is achieved, with a sensitivity of 10fg/μL, which can accurately distinguish DNA fragments of different sizes and segments, improve the safety and quality control of biological products, and meet strict regulatory standards.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995948A_ABST
    Figure CN118995948A_ABST
Patent Text Reader

Abstract

The invention discloses a kit for simultaneously detecting DNA (deoxyribonucleic acid) content and fragment size distribution of CHO (Chinese hamster ovary) cells and application of the kit. According to the kit, a long scattered repeat sequence (LINE-1) of a CHO cell genome is used as a detection target, and the target sequence is SEQ ID NO.1; comprising at least four sets of primer and probe combinations for amplifying the SEQ ID NO.1 sequence. The kit has the advantages that (1) the qPCR detection method capable of simultaneously detecting the content and size distribution of the DNA fragments of the CHO cells is established through screening analysis of a large number of CHO cell genome multi-copy conserved sequences, primer probe design and detection system optimization, the method is simple and rapid to operate, high in specificity and high in sensitivity, and the limit of quantitation of each detection system can reach 10fg / mu L; and (2) a PCR control system (IPC) is added in each system of the kit to monitor the qPCR reaction process, and the performance is strong and reliable. And (3) the coverage degree of the size of the fragment detected by the kit is high, reliable quality control evidence can be provided for the production of the biological product, and the safety of releasing the biological product is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of molecular biology and relates to the detection of residual DNA of host cells in biological products, and specifically to a kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells and its application. Background Art

[0002] Recombinant biological products such as monoclonal antibodies, recombinant protein drugs, vaccines, etc. are widely used in medicine and health. The expression systems for producing these biological products mainly include prokaryotic, yeast, plant, insect and mammalian cell expression systems. At present, Chinese Hamster Ovary (CHO) cells are the most widely used eukaryotic expression cell line in biopharmaceuticals. CHO cells not only have the characteristics of adherent growth, but also can be cultured in high-density suspension in serum-free and protein-free medium, which is suitable for large-scale industrial production. CHO cells belong to fibroblasts, have low endogenous protein secretion, and can efficiently separate and purify recombinant proteins. In addition, CHO cells can incorporate complex glycans into exogenously expressed proteins. Typical glycoproteins contain only a few N-linked glycans, which help protein folding and intracellular transport. CHO cells, as mammalian cells, are closer to the modifications in human cell proteins than the post-translational modifications of yeast cells and fruit fly cells in eukaryotic expression systems. Therefore, CHO cells are the preferred manufacturing host cells for more than 70% of protein drugs on the market.

[0003] Biological products usually contain residual host cell DNA. Although the residual DNA content is low, there are still certain safety risks, mainly reflected in the potential risks of tumorigenicity, infectivity, immunogenicity and mutagenicity. Therefore, since the 1980s, major international regulatory agencies have paid great attention to the amount of residual DNA in vaccines and the size distribution of residual fragments. For example, regulatory authorities have clear regulations on the residual amount of host cell residual DNA (HCD): the guidelines issued by the US FDA point out that the residual limit of HCD for biological products is 100pg / dose. For large-dose biological products such as monoclonal antibodies, the residual amount can be relaxed to 10ng / dose according to the source of residual DNA and the route of administration. The European Pharmacopoeia stipulates that the HCD limit of biological products is mostly no more than 10ng / dose, but the residual DNA limit standards for individual vaccines are more stringent, such as the residual DNA in the inactivated hepatitis A vaccine shall not exceed 100pg / dose. The "Chinese Pharmacopoeia 2020 Edition III" stipulates that the residual DNA of biological preparations produced with cell matrices cannot exceed 100pg / dose, and the residual DNA of vaccines produced with bacterial or fungal matrices cannot exceed 10ng / dose. In addition, China, the United States and other countries also have clear limit requirements on the size of residual HCD fragments. For example, the FDA clearly stated in the "Guidance Document on the Production of New Human Gene Therapy Products" that the HCD fragment must be less than 200bp; the NMPA Biological Products Pharmacy Department also pointed out in the draft for comments on the "Technical Guidelines for Pharmaceutical Research and Evaluation of Gene Therapy Products" that the HCD fragment must be less than 200bp. It is generally believed that the functional genes that may cause disease are at least 200bp or more, and the larger the residual DNA fragments, the higher the potential risk level. Therefore, the quality control of biological product manufacturers needs to detect the content and size distribution of residual DNA fragments in the finished product to ensure the safety and quality of biological products.

[0004] At present, the main analysis methods for residual DNA fragments in biological products in the industry are capillary electrophoresis (CE) and quantitative PCR (qPCR). Capillary electrophoresis is an electrophoresis technology that efficiently and quickly separates particles in a capillary according to their titer or distribution coefficient under the drive of a high-voltage electric field. It is divided into chip capillary electrophoresis (Chip CE) and capillary array electrophoresis (CAE), which can be used to determine the concentration and purity of nucleic acids, with a detection sensitivity of about 1 to 5 pg / μL. qPCR is a DNA quantification technology based on PCR reaction. A specific fluorescent probe is added at the same time as a pair of primers. The increase of the product can be indicated by a fluorescent signal, and the initial template in the sample can be quantitatively analyzed by real-time monitoring of the changes in the fluorescent signal in the PCR system. The quantitative PCR method is the exogenous DNA residual determination method confirmed by the Chinese Pharmacopoeia Commission in 2019, and it is also the only recommended standard method for detecting host residual DNA in biological products in the new version of USP. Compared with capillary electrophoresis, the detection limit of qPCR can reach the fg level, with higher sensitivity, and has the characteristics of simple operation, strong specificity, high throughput, accurate results, high degree of automation and real-time performance. At present, methods for detecting the residual DNA content in biological products have been established based on the qPCR method, but these methods cannot simultaneously detect the size distribution of residual DNA fragments in CHO cells. Therefore, there is an urgent need in the art for a detection method that can be used to quantitatively detect the size distribution of CHO cell DNA fragments in intermediates, semi-finished products and finished products of various biological products. Summary of the invention

[0005] Technical problem to be solved: In order to overcome the shortcomings of the existing technology, accurate quantification and analysis of the residual DNA content and fragment size distribution of CHO host cells in biological products are achieved; in view of this, the present invention provides a kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells and its application.

[0006] Technical solution: A kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells, wherein the kit uses the long interspersed repeat sequence (LINE-1) of the CHO cell genome as the detection target, the target sequence is SEQ ID NO.1, and the GeneBank accession number is: JH004828; and comprises at least 4 sets of primers and probe combinations for amplifying the SEQ ID NO.1 sequence.

[0007] Preferably, the lengths of the amplification products of the four sets of primer and probe combinations are: less than 100 bp, 100-200 bp, 200-300 bp, and more than 500 bp, respectively.

[0008] Furthermore, the probe is a dual quencher probe, the 5' end is labeled with a fluorescent reporter group, preferably FAM, or other groups with similar functions, and the 3' end is labeled with a quencher group, preferably SuperQuencher 1, or other groups with similar functions.

[0009] Preferably, the four sets of primer and probe combinations share the same forward primer, whose sequence is SEQ ID NO.2; the reverse primer sequences are SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6 respectively; the four sets of primer and probe combinations share the same probe, whose sequence is SEQ ID NO.7.

[0010] Further, in the first set of primers and probe combinations, the forward primer SEQ ID NO.2 binds to positions 105-129 of the sequence shown in SEQ ID NO.1; the reverse primer SEQ ID NO.3 binds to positions 178-202 of the sequence shown in SEQ ID NO.1; the probe SEQ ID NO.7 binds to positions 135-162 of the sequence shown in SEQ ID NO.1, and the length of the amplified product is 98 bp. In the second set of primers and probe combinations, the forward primer SEQ ID NO.2 binds to positions 105-129 of the sequence shown in SEQ ID NO.1; the reverse primer SEQ ID NO.4 binds to positions 223-243 of the sequence shown in SEQ ID NO.1; the probe SEQ ID NO.7 binds to positions 135-162 of the sequence shown in SEQ ID NO.1, and the length of the amplified product is 139 bp. The third set of primers and probes, the forward primer SEQ ID NO.2 binds to the 105-129 positions of the sequence shown in SEQ ID NO.1; the reverse primer SEQ ID NO.5 binds to the 293-315 positions of the sequence shown in SEQ ID NO.1; the probe SEQ ID NO.7 binds to the 135-162 positions of the sequence shown in SEQ ID NO.1, and the length of the amplified product is 211 bp. The fourth set of primers and probes, the forward primer SEQ ID NO.2 binds to the 105-129 positions of the sequence shown in SEQ ID NO.1; the reverse primer SEQ ID NO.6 binds to the 582-607 positions of the sequence shown in SEQ ID NO.1; the probe SEQ ID NO.7 binds to the 135-162 positions of the sequence shown in SEQ ID NO.1, and the length of the amplified product is 503 bp.

[0011] Preferably, the final concentrations of the four sets of primers and probes used in the amplification system are:

[0012] For the first set of primer and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 3 were 0.32 μM, and the final concentration of SEQ ID NO. 7 was 0.16 μM;

[0013] For the second set of primers and probes, the final concentrations of SEQ ID NO.2 and SEQ ID NO.4 were 0.4 μM, and the final concentration of SEQ ID NO.7 was 0.2 μM;

[0014] For the third set of primers and probes, the final concentrations of SEQ ID NO.2 and SEQ ID NO.5 were 0.4 μM, and the final concentration of SEQ ID NO.7 was 0.2 μM;

[0015] For the fourth set of primers and probe combinations, the final concentrations of SEQ ID NO.2 and SEQ ID NO.5 were 0.36 μM, and the final concentration of SEQ ID NO.7 was 0.18 μM.

[0016] Preferably, the kit includes IPC Mix, which is added to each set of primer and probe combinations respectively; the IPCMix includes an IPC template plasmid and an IPC primer probe combination, wherein the IPC template plasmid is an artificially modified cloning plasmid with a sequence of SEQ ID NO.8, the IPC forward primer sequence is SEQ ID NO.9, the IPC reverse primer sequence is SEQ ID NO.10, and the IPC probe sequence is SEQ ID NO.11.

[0017] Furthermore, the fluorescent reporter group at the 5' end of the IPC probe sequence is VIC, and the quencher group at the 3' end is BHQ1.

[0018] Preferably, the final concentrations of the IPC template plasmid and the IPC primer probe combination in the amplification system are:

[0019] The final concentration of SEQ ID NO.8 was 2.48×10 5 copies / mL; the final concentration of SEQ ID NO.9 and SEQ ID NO.10 was 0.3 μM; the final concentration of SEQ ID NO.11 was 0.15 μM.

[0020] Preferably, the kit includes 2×qPCR Mix, CHO standard and DNA diluent. Further, 2×qPCR Mix includes 50mM Tris-HCl pH 7.4, 0.2U / μL Taq enzyme, 0.5mM dNTPs, 100nM ROX reference dye, 8mM Mg 2+ , 20% glycerol.

[0021] Furthermore, the CHO standard is CHO cell genomic DNA, with a concentration of 30 ng / μL. The DNA diluent is prepared from Tween-20, EDTA, NaOH and Tris-HCl solution, wherein the concentration of Tween-20 is 0.1-0.2%, the concentration of Tris-HCl is 5.0-10.0 mM, the concentration of EDTA is 0.05-0.1 mM, and the pH is adjusted to 6.0-8.5 with NaOH solution.

[0022] Application of any of the above-mentioned kits in quantitative detection of CHO cell DNA content and fragment size distribution in intermediates, semi-finished products and finished products of biological products.

[0023] Preferably, the biological product is produced using a CHO cell expression system.

[0024] Preferably, the kit can accurately distinguish CHO cell DNA fragments in biological products with a size of less than 100 bp, 100-200 bp, 200-300 bp, and sequences above 500 bp, and the quantitative limit of each detection system is 10 fg / μL.

[0025] The kit is used for quantitatively detecting the CHO cell DNA content and fragment size distribution in the intermediate, semi-finished or finished product of a biological product, including but not limited to the following steps:

[0026] S1. Preparation of qPCR premix: determine the reagents and amounts required for the reaction, premix 2×qPCRMix with primer-probe combination and aliquot;

[0027] S2. Preparation of standard solution: dilute the CHO quantitative standard with DNA diluent to obtain a series of standard solutions with a concentration gradient;

[0028] S3. Preparation of negative quality control NCS: Take the sample matrix solution or DNA dilution solution in a centrifuge tube;

[0029] S4, sample addition: add sample, negative control and standard solution into qPCR premix to prepare qPCR reaction solution;

[0030] S5. Put the qPCR reaction solution into the qPCR instrument and set the amplification program for detection;

[0031] S6. Result analysis: copy the qPCR instrument results and analyze the test results.

[0032] The concentrations of the standard solutions of the series of concentration gradients in S2 are 300, 30, 3, 0.3, and 0.03 pg / μL. In S4, the samples are added in the order of negative quality control first, then standard solution, and the concentrations are from low to high. The amplification program in S5 is: pre-denaturation at 95°C for 2 minutes; 95°C for 5 seconds, 60°C for 30 seconds, 72°C for 30 seconds, and 40 cycles.

[0033] Beneficial effects: (1) The kit of the present invention has been subjected to a large number of screening and analysis of multi-copy conservative sequences of CHO cell genomes, primer probe design and detection system optimization, and a qPCR detection method capable of simultaneously detecting the content and size distribution of DNA fragments in CHO cells has been established. The method is simple and fast to operate, has strong specificity and high sensitivity, and the quantitative limit of each detection system can reach 10fg / μL. (2) The kit adds a PCR control system (IPC) inside each system to monitor the qPCR reaction process, and the performance is powerful and reliable. (2) The fragment size coverage detected by the kit is high, which can provide reliable quality control evidence for the production of biological products and improve the safety of released biological products. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 Amplification Plot (a) and Standard Curve (b) of detection system 1;

[0035] Figure 2 Amplification Plot (a) and Standard Curve (b) of detection system 2;

[0036] Figure 3 Amplification Plot (a) and Standard Curve (b) of detection system 3;

[0037] Figure 4 Amplification Plot (a) and Standard Curve (b) of detection system 4;

[0038] Figure 5 is the amplification curve of the quantitative limit test of detection system 1;

[0039] Figure 6 is the amplification curve of the quantitative limit test of detection system 2;

[0040] Figure 7 is the amplification curve of the quantitative limit test of detection system 3;

[0041] Figure 8 is the amplification curve of the quantitative limit test of detection system 4;

[0042] Fig. 9 It is the amplification curve of the specificity test of detection system 1;

[0043] Fig.10 Amplification curve for specificity test of detection system 2;

[0044] Fig.11 is the amplification curve of the specificity test of detection system 3;

[0045] Fig.12 This is the amplification curve of the specificity test of detection system 4. DETAILED DESCRIPTION

[0046] The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, modifications and substitutions made to the method, steps or conditions of the present invention all belong to the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.

[0047] Unless otherwise specified, the materials and reagents used in the present invention can be obtained from commercial sources. Among them, qPCRMix, DNA diluent, CHO DNA quantitative standard, Vero DNA quantitative standard, Human DNA quantitative standard, E. coli DNA quantitative standard, Pichia pastoris DNA quantitative standard and magnetic bead method trace residual nucleic acid extraction kit are all from Jiangsu Anke Huajie Biotechnology Co., Ltd.

[0048] The fluorescent quantitative PCR instruments used in the present invention are mainly ABI 7500, ABI QuantStudio Dx and ABI QuantStudio 5 from the United States.

[0049] The experimental methods used in the present invention are conventional methods unless otherwise specified. They mainly include the following steps

[0050] (1) Preparation of qPCR premix and standard solution

[0051] Determine the reagents and amounts required for the reaction, premix the concentrated premix with the primer probe and dispense. Use DNA diluent to dilute the CHO DNA quantitative standard by 10 times to prepare standard solutions of 300pg / μL, 30pg / μL, 3pg / μL, 0.3pg / μL, 0.03pg / μL, etc.

[0052] (2) qPCR reaction system

[0053] Detection system 30μL: 20μL qPCR premix + 10μL template;

[0054] Set the reaction program: pre-denaturation at 95°C for 2 min; 95°C for 5 s, 60°C for 30 s, 72°C for 30 s, 40 cycles.

[0055] (3) Data analysis

[0056] After amplification, set the threshold line to 0.02-0.2 and read the amplification efficiency, slope, and R 2 and the test values ​​of each sample.

[0057] (4) Result determination

[0058] Correlation coefficient R of the standard curve equation 2 It should be greater than 0.98, and the amplification efficiency should be between 90% and 110%;

[0059] The Ct values ​​of the no-template control (NTC) and interfering DNA were not detected or ≥35.00. The VIC signal was a valid "S"-shaped amplification curve.

[0060] Example 1 Screening target sequences and designing specific amplification primers and probe combinations

[0061] In order to meet the high sensitivity requirement, the present invention compares and analyzes the sequences according to the CHO cell genome data in the GenBank and DFAM databases, searches for the highly abundant conserved region sequences, and uses the software MEGA 11.0 and SnapGene 6.0 to perform conservative analysis on the sequences, and determines that the target sequence is the highly conserved long interspersed repeat sequence (LINE-1) fragment SEQ ID NO.1 of the CHO cell genome. The specific sequence is as follows:

[0062] AACTTATGGGACACCCTGAAAGCAGTGCTAAGAGGGAAGTTCATAGCACTAAGTGCTC

[0063] ACATGAAGAAACTGGAGGAAAGTCACATTAGAGAATTGACAGAACAACTGAAAGCTT

[0064] TAGAGCAAGAGGAAGCAAACTCACCAGGAGGAGTAGACGCCAGGAAATAATCAACC

[0065] TGAGAGCCGAAATCAACAAAGTAGAAACTAGGAAAACAGTACAAAGAATCAATGAAA

[0066] CAAAGAGTTGGTTCTTTGAGAAGATCAACAAGATAGACAAGCCTCTAGCCAAACTAAC

[0067] CAAAAGGCAGAGAGAGAGCATGCTAATTAACAAAATCAGAAATGAAAAGGGAGACAT

[0068] AACAACGGACACTGAGGAAATCCAGAGAATCTTTAGGTCATACTTTGAAAACCTGTAT

[0069] TCCACAAAATTGGAAAACCTAAAGGAAATGGACAACTTTCTGGATAAATATCACTTAC

[0070] CAAAATTAAATCAAGATCAGATAGACAGTTTAAATCGAACTATAACCCCTAATGAGAT

[0071] AGAAGCAGTAATCAAAAGCCTCCCAACCAAAAAAAGCCCAGGGCCAGATGGCTTCAC

[0072] TGCAGAATTCTACCAGAAATTCAAACAAGAGCTAATTCCAGTACTCCTCAAACTGTTCCACACAATAGAAGCAGATGGGATATTGCCAAAC.

[0073] In order to better analyze and monitor the quality of biological products, the present invention is used to quantitatively analyze the size distribution of CHO cell DNA fragments in samples. According to four amplification products of less than 100 bp, 100-200 bp, 200-300 bp and more than 500 bp, the primer probe sequence is designed using Primer Premier 5.0. The primer probe of the present invention can specifically bind to the sequence shown in SEQ ID NO.1 of the CHO cell genome. The specific primer probe sequence is shown in Table 1 below:

[0074] Table 14 Specific sequences of primer and probe combinations

[0075]

[0076] In order to monitor the qPCR reaction process, an internal PCR control system (IPC) was added, that is, IPC Mix was added to all four detection systems, where the IPC template plasmid was the artificially modified cloned plasmid SEQ ID NO.8, and the specific sequence is as follows:

[0077] CGCCACGGTCACGGAGCACGAGAAATTCCACTTTACCCACCGTGAACGCCGTAAT CATTGGATCTACTTTCCTTCTACGCCAAGTAAATCAATTGTTTGCTTCAACCATCATTTCGGCTTTGAACGTGCCGCTTGATACTGACA.

[0078] The forward primer sequence is SEQ ID NO.9; the reverse primer sequence is SEQ ID NO.10; the probe sequence is SEQ ID NO.11. The specific primer and probe sequences are shown in Table 2 below:

[0079] Table 2 IPC Mix specific sequence

[0080] Sequence number Sequence (5'→3') Forward primer SEQ ID NO.9 CGCCACGGTCACGGAGCAC Reverse primer SEQ ID NO.10 TCAGTATCAAGCGGCACGTT Probe sequence SEQ ID NO.11 VIC-GTGAACGCCGTAATCATTGGATCTA-BHQ1

[0081] The four amplified fragment detection systems of the present invention all use the same forward primer and probe, with only the reverse primer being different. The primer pairs and probes are combined to obtain four amplified fragment detection systems, and the specific combinations are shown in Table 3 below:

[0082] Table 34 Details of primer and probe combinations

[0083]

[0084] Example 2 Performance Study of CHO Cell DNA Detection System

[0085] 1. Linear range

[0086] Using the optimized reaction system and reaction procedure, the four amplification fragment detection systems were used to amplify and detect five CHO DNA quantitative standards with known concentrations (300 pg / μL, 30 pg / μL, 3 pg / μL, 0.3 pg / μL and 0.03 pg / μL), and the standard curve correlation coefficient (R 2 ) and amplification efficiency (Eff). The results showed that the standard curves R 2 ≥0.990, amplification efficiency was in the range of 90% to 110.0%, NTC Ct value was ≥35.00, the test results met the standard requirements of fluorescent quantitative PCR (qPCR) reagents, and the linear range of each detection system was 3×10 2 pg / μL~3×10 -2 pg / μL.

[0087] The amplification curve and linear relationship diagram of the standard curve of detection system 1-detection system 4 are shown in Figures 1 to 4The specific results are shown in Table 4 below:

[0088] Table 4. Linear range test results of four amplification fragment detection systems

[0089]

[0090] 2. Limit of Quantitation

[0091] Using the optimized reaction system and reaction procedure, the four amplification fragment detection systems were used to amplify and detect five known concentrations (3×10 2 pg / μL~3×10 -2 pg / μL) of CHO DNA quantitative standards, and quantitatively determined the detection Ct values ​​of each detection system at template amounts of 30fg / μL and 10fg / μL (10 replicate wells each), substituted the detection Ct values ​​into the standard curve to calculate the detection concentration of each well, and calculated the coefficient of variation (CV) and deviation of the detection concentration of 10 replicate wells. The results showed that the CV and deviation of the detection concentrations of 30fg / μL and 10fg / μL of the four detection systems were ≤20.0%, so the limit of quantification could reach 10fg / μL.

[0092] The amplification curves of the quantitative limit test of detection system 1-detection system 4 are as follows Figures 5 to 8 The specific results are shown in Table 5 below:

[0093] Table 5. Quantitation limit test results of four amplified fragment detection systems

[0094]

[0095] 3. Exclusivity

[0096] Using the optimized reaction system and reaction procedure, the interference of host cell genomes Vero, E. coli, Pichia pastoris and Human DNA commonly used in amplification detection production on four different amplification fragment detection systems was tested. The concentration of the commonly used host cell genome interfering DNA added was 30pg. The results showed that the amplification of the same concentration of CHO positive control samples was accurate in quantitative analysis, and no target signal was detected or the detection Ct value was ≥35.00 when amplifying the commonly used host cell genome interfering DNA. Therefore, the interference with the four established detection systems was small, and the system showed better specificity.

[0097] The amplification curves of the specificity tests of detection system 1 to detection system 4 are as follows: Figures 9-10 The specific results are shown in Table 6 below:

[0098] Table 6. Specificity test results of four amplified fragment detection systems

[0099]

[0100] 4. Freeze-thaw stability

[0101] After the four amplification fragment detection system reagents were repeatedly frozen and thawed at least 5 times (freezing temperature was -20°C), 5 amplification detections of known concentrations (3×10 2 pg / μL~3×10 -2 pg / μL) of CHO DNA quantitative standard, and calculate the standard curve correlation coefficient (R 2 ) and amplification efficiency (Eff). At the same time, the Ct value of each detection system at the lowest point of the standard curve with a template amount of 30fg / μL (each 3 replicate wells) was quantitatively determined, and the detection Ct value was substituted into the standard curve to calculate the detection concentration of each well, and the coefficient of variation (CV) and deviation of the 3 replicate wells detection concentration were calculated. The results showed that the standard curve R 2 ≥0.990, amplification efficiency was in the range of 90% to 110.0%, NTC Ct value was ≥35.00, and CV and deviation of 30fg / μL detection concentration were both ≤20.0%, which means that the performance of the four detection systems was not affected after five repeated freeze-thaw cycles.

[0102] The specific results are shown in Table 7 below:

[0103] Table 7. Freeze-thaw stability test results of four amplified fragment detection systems

[0104]

[0105] In summary, the present invention provides a primer probe combination, detection method and kit for quantitatively detecting the size distribution of residual DNA fragments of CHO cells using real-time fluorescence quantitative PCR (Real-time qPCR) technology, which is used for quantitative analysis of the size distribution of residual DNA fragments of CHO cells in biological product samples, and can provide reliable quality control evidence for the production of biological products, and provide important support for the research and development and safe production of recombinant protein drugs. The detection method is simple to operate, has strong specificity, can distinguish interfering DNA such as Vero cells, E. coli, Pichia pastoris and Human cells, the kit has high sensitivity, and the quantitative limit of each detection system can reach 10fg / μL. An internal PCR control system (IPC) is added to each test to monitor the qPCR reaction process to ensure data reliability. The kit passes the freeze-thaw stability test and has reliable performance.

Claims

1. A kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells, characterized in that: The kit uses the long interspersed repeat sequence (LINE-1) of the CHO cell genome as the detection target, and the target sequence is SEQ ID NO.1; It includes at least 4 sets of primers and probe combinations for amplifying the sequence of SEQ ID NO.

1.

2. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 1, characterized in that: The lengths of the amplified products of the four sets of primers and probe combinations are respectively: less than 100 bp, 100-200 bp, 200-300 bp, and more than 500 bp.

3. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 1, characterized in that: The four sets of primer and probe combinations share the same forward primer, whose sequence is SEQ ID NO.2; the reverse primer sequences are SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6 respectively; the four sets of primer and probe combinations share the same probe, whose sequence is SEQ ID NO.

7.

4. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 3, characterized in that: The final concentrations of the four sets of primers and probes used in the amplification system are: For the first set of primer and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 3 were 0.32 μM, and the final concentration of SEQ ID NO. 7 was 0.16 μM; For the second set of primers and probe combinations, the final concentrations of SEQ ID NO.2 and SEQ ID NO.4 were 0.4 μM, and the final concentration of SEQ ID NO.7 was 0.2 μM; For the third set of primers and probes, the final concentrations of SEQ ID NO.2 and SEQ ID NO.5 were 0.4 μM, and the final concentration of SEQ ID NO.7 was 0.2 μM; For the fourth set of primers and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 5 were 0.36 μM, and the final concentration of SEQ ID NO. 7 was 0.18 μM.

5. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 1, characterized in that: The kit includes IPC Mix, which is added to each set of primer and probe combinations respectively; the IPC Mix includes an IPC template plasmid and an IPC primer-probe combination, wherein the IPC template plasmid is an artificially modified cloning plasmid with a sequence of SEQ ID NO.8, the IPC forward primer sequence is SEQ ID NO.9, the IPC reverse primer sequence is SEQ ID NO.10, and the IPC probe sequence is SEQ ID NO.

11.

6. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 5, characterized in that: The final concentrations of the IPC template plasmid and the IPC primer probe combination in the amplification system are: The final concentration of SEQ ID NO.8 was 2.48×10 5 copies / mL; the final concentration of SEQ ID NO.9 and SEQ ID NO.10 was 0.3 μM; the final concentration of SEQ ID NO.11 was 0.15 μM.

7. The kit for simultaneously detecting the DNA content and fragment size distribution of CHO cells according to claim 1, characterized in that: The kit includes 2×qPCR Mix, CHO quantitative standard and DNA diluent; wherein 2×qPCR Mix includes 50mMTris-HCl pH 7.4, 0.2U / μL Taq enzyme, 0.5mM dNTPs, 100nM ROX reference dye, 8mM Mg 2+ , 20% glycerol.

8. Use of the kit according to any one of claims 1 to 7 for quantitatively detecting the CHO cell DNA content and fragment size distribution in intermediates, semi-finished products and finished products of biological products.

9. The use according to claim 8, characterized in that: The biological product is produced by adopting a CHO cell expression system.

10. The use according to claim 8, characterized in that: The kit can accurately distinguish the sequences of CHO cell DNA fragments with sizes below 100 bp, 100-200 bp, 200-300 bp, and above 500 bp in biological products, and the quantitative limit of each detection system reaches 10 fg / μL.

Citation Information

Cited By

  • CHO cell residual DNA detection method and application thereof

    CN120310930A